Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo. Try Elite Free for 7 Days
Login Sign up free
Home Screener Maps Charts News Groups Insider Futures Forex Crypto Portfolio Calendar
Pricing

New upgrade:   Journal your trades with more detail

Read How
Market News Market Pulse Stocks News ETF News Crypto News

YD Bio Limited

Contributing Author

Recent Articles by YD Bio Limited

Aug-25
YD Bio Announces Peer-Reviewed Publication in Nutrients, Co-Authored with Physicians from the Taiwan Chronic Disease Healthcare Association and the Future Health Institute YDES GlobeNewswire
Aug-11
YD Bio Launches a Physician-Partnership Initiative in Taiwan with the Announcement of Two Nutraceutical Products in Collaboration with the Taiwan Chronic Disease Healthcare Association and the Future Health Institute YDES +8.98% GlobeNewswire
Aug-04
YD Bio Highlights Peer-Reviewed Publication on New Computational Framework for Keratoconus Research YDES GlobeNewswire
Jul-28
YD Bio Launches Cross-Border Cancer Testing Pilot with Numia Health to Evaluate Expanded Access to Molecular Diagnostics in Canada YDES GlobeNewswire
Jul-23
YD Bio and EG BioMed Conclude Successful Exhibition at BIO Asia-Taiwan 2026, Highlighting Innovations in Ophthalmology, Oncology Diagnostics, and Clinical Services YDES -7.69% GlobeNewswire
Jul-02
YD Bio Expands U.S. Laboratory Footprint to 46 States, Strengthening DNA-Methylation Early Cancer Detection Operations YDES -17.75% GlobeNewswire
Apr-30
YD Bio Limited Reports Full Year 2025 Financial Results YDES YDES -5.88% GlobeNewswire
Mar-31
YD Bio and EG BioMed Jointly Launch Nationwide Telehealth Platform to Accelerate Commercialization of Cancer Detection and Decentralized Clinical Services Across the United States YDES GlobeNewswire
Mar-17
YD Bio Limited CEO Dr. Ethan Shen Details Strategic Roadmap for Integrated Oncology Ecosystem YDES -8.55% GlobeNewswire
Feb-25
YD Bio Limited Announces Strategic Partnership with YC Biotech Co., Ltd. to Establish a Taiwan-U.S. Dual-Core Regulatory Platform YDES GlobeNewswire
Jan-29
YD Bio Limited Enters into Binding Letter of Intent to Acquire Safe Save Medical Cell Sciences & Technology Co., Ltd., Bolstering Leadership in Advanced Immunocell Therapy YDES -9.89% GlobeNewswire
Jan-06
YD Bio Enters into MOU to Merge with EG BioMed, Advancing DNA Methylation-Driven AI Platforms for Cancer Diagnostics and Drug Development YDES -8.04% GlobeNewswire
Jan-05
YD Bio Limited Announces Major Milestones and Unveils Robust 2026 Clinical and Commercial Roadmap YDES +5.67% GlobeNewswire
Dec-16
YD Bio Limited Expands U.S. Presence with Newly Planned California Facilities and Operations Center YDES GlobeNewswire
Dec-09
YD Bio Limited Showcases Its Innovative Diagnostic and Precision Medicine Portfolios at the 9th Healthcare EXPO TAIWAN YDES -18.42% GlobeNewswire
Dec-02
YD Bio Limited Expands OkaiDx Testing Portfolio to Pancreatic and Colorectal Cancer Detection Across the U.S. and Provides Clinical Research Update on Pancreatic Cancer Early Detection YDES GlobeNewswire
Nov-24
YD Bio Limited Announces U.S. Ophthalmology Market Entry, Advances Across Diagnostics and LSC Exosome Therapeutics YDES GlobeNewswire
Nov-05
YD Bio and EG BioMed Expand U.S. Access to OkaiDx, a cfDNA-Methylation Blood Test for Post-Treatment Breast Cancer Monitoring YDES GlobeNewswire
Oct-20
YD Bio Ltd. Rings Nasdaq Opening Bell to Celebrate Listing under Ticker YDES YDES GlobeNewswire
Oct-10
YD Bio Business Partner EG Biomed Achieves CAP Accreditation, Advancing U.S. Clinical Testing Capabilities YDES -6.95% GlobeNewswire
Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)